Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariën, Kevin K., Heyndrickx, Leo, Michiels, Johan, Vereecken, Katleen, Van Lent, Kurt, Coppens, Sandra, Willems, Betty, Pannus, Pieter, Martens, Geert A., Van Esbroeck, Marjan, Goossens, Maria E., Marchant, Arnaud, Bartholomeeusen, Koen, Desombere, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904765/
https://www.ncbi.nlm.nih.gov/pubmed/35260578
http://dx.doi.org/10.1038/s41541-022-00459-z
_version_ 1784665016164679680
author Ariën, Kevin K.
Heyndrickx, Leo
Michiels, Johan
Vereecken, Katleen
Van Lent, Kurt
Coppens, Sandra
Willems, Betty
Pannus, Pieter
Martens, Geert A.
Van Esbroeck, Marjan
Goossens, Maria E.
Marchant, Arnaud
Bartholomeeusen, Koen
Desombere, Isabelle
author_facet Ariën, Kevin K.
Heyndrickx, Leo
Michiels, Johan
Vereecken, Katleen
Van Lent, Kurt
Coppens, Sandra
Willems, Betty
Pannus, Pieter
Martens, Geert A.
Van Esbroeck, Marjan
Goossens, Maria E.
Marchant, Arnaud
Bartholomeeusen, Koen
Desombere, Isabelle
author_sort Ariën, Kevin K.
collection PubMed
description We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.
format Online
Article
Text
id pubmed-8904765
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89047652022-03-23 Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant Ariën, Kevin K. Heyndrickx, Leo Michiels, Johan Vereecken, Katleen Van Lent, Kurt Coppens, Sandra Willems, Betty Pannus, Pieter Martens, Geert A. Van Esbroeck, Marjan Goossens, Maria E. Marchant, Arnaud Bartholomeeusen, Koen Desombere, Isabelle NPJ Vaccines Brief Communication We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron. Nature Publishing Group UK 2022-03-08 /pmc/articles/PMC8904765/ /pubmed/35260578 http://dx.doi.org/10.1038/s41541-022-00459-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Communication
Ariën, Kevin K.
Heyndrickx, Leo
Michiels, Johan
Vereecken, Katleen
Van Lent, Kurt
Coppens, Sandra
Willems, Betty
Pannus, Pieter
Martens, Geert A.
Van Esbroeck, Marjan
Goossens, Maria E.
Marchant, Arnaud
Bartholomeeusen, Koen
Desombere, Isabelle
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title_full Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title_fullStr Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title_full_unstemmed Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title_short Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
title_sort three doses of bnt162b2 vaccine confer neutralising antibody capacity against the sars-cov-2 omicron variant
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904765/
https://www.ncbi.nlm.nih.gov/pubmed/35260578
http://dx.doi.org/10.1038/s41541-022-00459-z
work_keys_str_mv AT arienkevink threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT heyndrickxleo threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT michielsjohan threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT vereeckenkatleen threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT vanlentkurt threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT coppenssandra threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT willemsbetty threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT pannuspieter threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT martensgeerta threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT vanesbroeckmarjan threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT goossensmariae threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT marchantarnaud threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT bartholomeeusenkoen threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant
AT desombereisabelle threedosesofbnt162b2vaccineconferneutralisingantibodycapacityagainstthesarscov2omicronvariant

Ejemplares similares